Hurdle

Diagnostic Infrastructure to scale your healthcare solution

London, United Kingdom · Founded 2017 · $8.0M raised

Headquarters
London
Employees
11–50
Founded
2017
Business Model
B2B
Website
hurdle.bio
Total Funding
$8.0M
Last Round
$8.0M Series AAug 2024
Rounds
1

About

Hurdle is a UK-based diagnostics-as-a-service platform that provides end-to-end diagnostic infrastructure for healthcare providers, telehealth companies, and clinical research organizations. Its modular platform covers biomarker R&D, sample collection kits, lab testing, logistics, and digital patient experience, enabling businesses to launch and scale diagnostic solutions without building infrastructure from scratch.

Summary

Hurdle is a Biotech company based in London, United Kingdom, founded in 2017. It has raised $8.0M in total across 1 round, most recently a $8.0M Series A round in Aug 2024.

Tech & App Stack

9 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AAug 2024
$8.0M

Similar Companies